{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:00:53Z","timestamp":1747166453079,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jvacx.2023.100407","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T01:07:20Z","timestamp":1700269640000},"page":"100407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Distinctions between survivors and non-survivors with SARS-CoV-2 vaccine-induced thrombotic thrombocytopenia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0733-0910","authenticated-orcid":false,"given":"Alejandra","family":"Castro-Varela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Karen","family":"Garza Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanna","family":"Barrios-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Ambriz Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-3957","authenticated-orcid":false,"given":"Paulina","family":"Abascal-Lanzagorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda","family":"Reyes-Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Italia Tatna\u00ed","family":"C\u00e1rdenas-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-7260","authenticated-orcid":false,"given":"E.J.","family":"Solorzano-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7664-656X","authenticated-orcid":false,"given":"Claudio","family":"S\u00e1nchez-Pizarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Fernando de los R\u00edos Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7149-8334","authenticated-orcid":false,"given":"Eduardo","family":"Vazquez-Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-7405","authenticated-orcid":false,"given":"Carlos","family":"Jerjes-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2023.100407_b0005","unstructured":"COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. [cited 2021 May 17]. Available from: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"10.1016\/j.jvacx.2023.100407_b0010","doi-asserted-by":"crossref","unstructured":"Cines DB, Bussel JB. SARS-CoV-2 Vaccine\u2013Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Apr 16;NEJMe2106315.","DOI":"10.1056\/NEJMe2106315"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100407_b0015","first-page":"612","article-title":"Thrombocytopenia","volume":"85","author":"Gauer","year":"2012","journal-title":"Am Fam Physician"},{"issue":"11","key":"10.1016\/j.jvacx.2023.100407_b0020","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100407_b0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2018-06-820746","article-title":"Treatment of bleeding complications in patients on anticoagulant therapy","volume":"133","author":"Piran","year":"2019","journal-title":"Blood"},{"issue":"7524","key":"10.1016\/j.jvacx.2023.100407_b0030","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bmj.38636.593461.68","article-title":"Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources","volume":"331","author":"Greenhalgh","year":"2005","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100407_b0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ EBM"},{"issue":"39","key":"10.1016\/j.jvacx.2023.100407_b0040","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1093\/eurheartj\/ehab592","article-title":"Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score","volume":"42","author":"Hwang","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvacx.2023.100407_b0045","doi-asserted-by":"crossref","unstructured":"Bellavite P. Causality assessment of adverse events following immunization: the problem of multifactorial pathology. F1000Res. 2020 Apr 14;9:170.","DOI":"10.12688\/f1000research.22600.2"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100407_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.14482","article-title":"How do we approach thrombocytopenia in critically ill patients?","volume":"177","author":"Thachil","year":"2017","journal-title":"Br J Haematol"},{"issue":"S3","key":"10.1016\/j.jvacx.2023.100407_b0055","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.21037\/cdt.2017.11.08","volume":"7","author":"Thrombosis","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"issue":"10","key":"10.1016\/j.jvacx.2023.100407_b0060","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvacx.2023.100407_b0065","doi-asserted-by":"crossref","unstructured":"Thaler J, Ay C, Gleixner KV, Hauswirth AW, Cacioppo F, Grafeneder J, et al. Successful treatment of vaccine\u2010induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost. 2021 Apr 20;jth.15346.","DOI":"10.1111\/jth.15346"},{"key":"10.1016\/j.jvacx.2023.100407_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00127-4","article-title":"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials","author":"Yang","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10277","key":"10.1016\/j.jvacx.2023.100407_b0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"10240","key":"10.1016\/j.jvacx.2023.100407_b0080","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"issue":"10275","key":"10.1016\/j.jvacx.2023.100407_b0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jvacx.2023.100407_b0090","doi-asserted-by":"crossref","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B, et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021 Apr 21;NEJMoa2101544.","DOI":"10.1056\/NEJMoa2101544"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100407_b0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.jvacx.2023.100407_b0100","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100407_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jvacx.2023.100407_b0110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials","volume":"324","author":"Xia","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100407_b0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jvacx.2023.100407_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102988","article-title":"Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review","volume":"73","author":"Ahmed","year":"2022","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.jvacx.2023.100407_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jvacx.2023.100407_b0130","doi-asserted-by":"crossref","unstructured":"Hafeez MU, Ikram M, Shafiq Z, Sarfraz A, Sarfraz Z, Jaiswal V, et al. COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis. Clin Appl Thromb Hemost. 2021 Jan;27:107602962110488.","DOI":"10.1177\/10760296211048815"},{"key":"10.1016\/j.jvacx.2023.100407_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-021-02626-w","article-title":"A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines","author":"Elberry","year":"2022","journal-title":"J Thromb Thrombolysis [Internet]"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100407_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2023.100407_b0145","doi-asserted-by":"crossref","unstructured":"Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA [Internet]. 2021 Sep 3 [cited 2021 Sep 6]; Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784015.","DOI":"10.1001\/jama.2021.15072"},{"issue":"22","key":"10.1016\/j.jvacx.2023.100407_b0150","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jvacx.2023.100407_b0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WNO.0000000000001122","article-title":"Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic","volume":"40","author":"Medicherla","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jvacx.2023.100407_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.inat.2021.101091","article-title":"Cerebral venous sinus thrombosis in patients with COVID-19 infection","volume":"24","author":"Abouhashem","year":"2021","journal-title":"Interdiscipl Neurosurg"},{"issue":"11","key":"10.1016\/j.jvacx.2023.100407_b0165","article-title":"COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management","volume":"5","author":"Fraiman","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100407_b0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MBC.0000000000001113","article-title":"Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis","volume":"33","author":"Matar","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"10.1016\/j.jvacx.2023.100407_b0175","article-title":"COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis","volume":"29","author":"Bilotta","year":"2021","journal-title":"Front Immunol"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T07:14:47Z","timestamp":1719990887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"alternative-id":["S2590136223001481"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100407","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctions between survivors and non-survivors with SARS-CoV-2 vaccine-induced thrombotic thrombocytopenia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100407"}}